Clonal Origin of Recurrent Meningiomas
暂无分享,去创建一个
R. Wellenreuther | R. Warnick | A. Deimling | J. Tew | A. Menon | V. Velthoven | J. Larson | G. Balko | A. Stangl | A. Deimling
[1] D. Lenartz,et al. Clonality of multiple meningiomas , 1997 .
[2] T. Houseal,et al. Frequent loss of chromosome 14 in atypical and malignant meningioma: identification of a putative `tumor progression' locus , 1997, Oncogene.
[3] D. Barton,et al. Molecular genetic investigation of the neurofibromatosis type 2 tumor suppressor gene in sporadic meningioma. , 1996, Journal of neurosurgery.
[4] R. Wellenreuther,et al. Allelic losses on chromosomes 14, 10, and 1 in atypical and malignant meningiomas: a genetic model of meningioma progression. , 1995, Cancer research.
[5] J. Tew,et al. Evidence for clonal spread in the development of multiple meningiomas. , 1995, Journal of neurosurgery.
[6] X. Estivill,et al. Predominant occurrence of somatic mutations of the NF2 gene in meningiomas and schwannomas , 1995, Genes, chromosomes & cancer.
[7] D. Louis,et al. Evidence for Subarachnoid Spread in the Development of Multiple Meningiomas , 1995, Brain pathology.
[8] D. Lenartz,et al. Analysis of the neurofibromatosis 2 gene reveals molecular variants of meningioma. , 1995, The American journal of pathology.
[9] A. Hagemeijer,et al. Frequent NF2 gene transcript mutations in sporadic meningiomas and vestibular schwannomas. , 1994, American journal of human genetics.
[10] J. Gusella,et al. Exon scanning for mutation of the NF2 gene in schwannomas. , 1994, Human molecular genetics.
[11] V. P. Collins,et al. Chromosomal deletions in anaplastic meningiomas suggest multiple regions outside chromosome 22 as important in tumor progression , 1994, International journal of cancer.
[12] Olivier Delattre,et al. Evidence for the complete inactivation of the NF2 gene in the majority of sporadic meningiomas , 1994, Nature Genetics.
[13] D. Louis,et al. A rapid and non‐radioactive PCR based assay for the detection of allelic loss in human gliomas , 1993, Neuropathology and applied neurobiology.
[14] S. Pulst,et al. Alteration in a new gene encoding a putative membrane-organizing protein causes neuro-fibromatosis type 2 , 1993, Nature.
[15] J. Haines,et al. A novel moesin-, ezrin-, radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor , 1993, Cell.
[16] B. Scheithauer,et al. Histological Typing of Tumours of the Central Nervous System , 1993, World Health Organization.
[17] H. Zoghbi,et al. Methylation of HpaII and HhaI sites near the polymorphic CAG repeat in the human androgen-receptor gene correlates with X chromosome inactivation. , 1992, American journal of human genetics.
[18] S. Perrin,et al. Clonality in myeloproliferative disorders: analysis by means of the polymerase chain reaction. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[19] B Budowle,et al. Analysis of the VNTR locus D1S80 by the PCR followed by high-resolution PAGE. , 1991, American journal of human genetics.
[20] R. Martuza,et al. Clonal analysis of human meningiomas and schwannomas. , 1990, Cancer research.
[21] D. Goldsher,et al. Recurrence of intracranial meningiomas: the role played by regional multicentricity. Part 2: Clinical and radiological aspects. , 1986, Journal of neurosurgery.
[22] Y. Doron,et al. Recurrence of intracranial meningiomas: the role played by regional multicentricity. , 1986, Journal of neurosurgery.
[23] M. Khan,et al. The recurrence of intracranial meningiomas after surgical treatment. , 1983, Journal of neurosurgery.